Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FQJYT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $90,994
Award facts
- Contract value 100% obligated
- $90,994.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at approximately $91,000 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pens on September 23, 2025, with a completion date of September 24, 2025. This competitively awarded, firm fixed-price contract requires delivery to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent is a biologic medication used to treat various inflammatory conditions, and this delivery order represents a discrete purchase under a broader contracting vehicle supporting military and federal healthcare procurement.
This delivery order falls under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen maintains an extensive portfolio of medical product deliveries across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies. The contract demonstrates the company's ongoing capability to fulfill federal healthcare supply requirements through open competition and aligns with the Defense Logistics Agency's procurement strategy for supporting Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FQJYT?
SPE2DB25FQJYT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FQJYT worth?
The government has obligated $90,994 on SPE2DB25FQJYT.
Is contract SPE2DB25FQJYT an order under another contract?
Yes. SPE2DB25FQJYT is a delivery order under SPE2DB25D3005, an indefinite delivery contract.
Was contract SPE2DB25FQJYT competed?
The extent of competition for SPE2DB25FQJYT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award